Evaluating the Use of Perfusion-Only Q-SPECT as a Diagnostic Tool for CTEPH in Low-Resource Environments: A Study on Minimizing Unnecessary Referrals to Specialized Centers - Report - MDSpire

Evaluating the Use of Perfusion-Only Q-SPECT as a Diagnostic Tool for CTEPH in Low-Resource Environments: A Study on Minimizing Unnecessary Referrals to Specialized Centers

  • By

  • Seckin Bilgic

  • Ilgim Vardaloglu

  • Irem Koroglu

  • Emre Karayel

  • January 27, 2026

  • 0 min

Share

Clinical Report: Evaluating Perfusion-Only Q-SPECT for CTEPH Diagnosis

Overview

This study evaluates the diagnostic performance of perfusion-only Q-SPECT in patients suspected of having chronic thromboembolic pulmonary hypertension (CTEPH). The findings suggest that Q-SPECT can effectively reduce unnecessary referrals to specialized centers while maintaining high negative predictive value.

Background

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but treatable condition that often goes undiagnosed due to limited access to diagnostic resources. Accurate diagnosis is essential for timely intervention, as treatment options like pulmonary endarterectomy can significantly improve patient outcomes. In low-resource settings, the lack of advanced imaging modalities complicates the diagnostic process, leading to delays in care.

Data Highlights

{'normal_perfusion_scan_negative_predictive_value': 'Provide specific numerical value', 'referral_reduction_potential': 'Provide specific numerical value or percentage'}

Key Findings

  • Perfusion-only Q-SPECT can serve as a reliable rule-out tool for CTEPH.
  • High negative predictive value associated with the absence of perfusion defects.
  • Study included 42 patients with suspected CTEPH, stratified based on Q-SPECT findings.
  • Q-SPECT eliminates the need for ventilation agents, making it feasible in resource-limited settings.
  • Diagnostic delays in CTEPH are linked to poorer patient prognosis.

Clinical Implications

Clinicians in low-resource environments can utilize perfusion-only Q-SPECT to effectively rule out CTEPH, thereby minimizing unnecessary referrals to specialized centers. This approach can streamline the diagnostic process and ensure timely treatment for patients with confirmed disease.

Conclusion

Perfusion-only Q-SPECT presents a valuable diagnostic alternative for CTEPH in settings with limited resources, potentially improving patient management and outcomes. Further studies are warranted to validate these findings across diverse populations.

References

  1. European Radiology, 2025 -- High-Resolution Photon-Counting Detector CT Findings of Lung Microvasculopathy in Patients with Chronic Thromboembolic Pulmonary Hypertension
  2. European Radiology, 2025 -- Automated Bayesian Approach for Assessing the Degree and Distribution of Pulmonary Perfusion Alterations in CT Pulmonary Angiography for CTEPH
  3. European Radiology, 2023 -- Evaluation of Pulmonary Perfusion via Dual-Layer Dual-Energy CT for Distinguishing Acute Pulmonary Embolism from Chronic Thromboembolic Pulmonary Hypertension
  4. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension | European Heart Journal | Oxford Academic
  5. Perfusion-only Q-SPECT as a rule-out tool for CTEPH in resource-limited settings: a feasibility study on reducing unnecessary referrals to tertiary centers - PMC
  6. European Radiology — Evaluating the Role of CT Perfusion as a Screening Method for Patients with Acute Stroke
  7. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension | European Heart Journal | Oxford Academic
  8. Perfusion-only Q-SPECT as a rule-out tool for CTEPH in resource-limited settings: a feasibility study on reducing unnecessary referrals to tertiary centers - PMC
  9. Worldwide CTEPH Registry Long-Term Outcomes - American College of Cardiology

Original Source(s)

Related Content